Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1124-1131
doi: 10.1161/CIRCULATIONAHA.106.627323
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Acquatella, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Acquatella, H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cardiomyopathy
*Chagas Disease
Related Collections
Right arrow Other heart failure
Right arrow Congestive
Right arrow Echocardiography

(Circulation. 2007;115:1124-1131.)
© 2007 American Heart Association, Inc.


Heart Disease in Latin America

Echocardiography in Chagas Heart Disease

Harry Acquatella, MD

From the Faculty of Medicine Universidad Central de Venezuela, Hospital Universitario and Centro Medico, Caracas, Venezuela.

Correspondence to Dr Harry Acquatella, 275 Centro Medico, San Bernardino, Caracas 1011, Venezuela. E-mail hacquatella{at}cantv.net

Received March 15, 2006; accepted August 8, 2006.

Background— Chagas heart disease is a frequent cause of morbidity and mortality in Latin America. Echocardiography provides useful diagnostic and prognostic information and is an important tool in the management of patients with Chagas disease.

Methods and Results— A search for relevant publications was obtained from MEDLINE, LILACS, and SCIELO sources. Acute Chagas myocarditis is a rare disorder in which pericardial effusion is frequent. Echocardiography may exclude pericardial tamponade in case of heart failure. Chronic Chagas cardiomyopathy evolves for several decades after the infection. Epidemiological history, positive serology, and suggestive clinical and ECG abnormalities establish the diagnosis. About three quarters of chronic Chagas cardiomyopathy subjects remain asymptomatic with normal (indeterminate form) or abnormal ECGs. Early Doppler abnormalities includes prolongation of isovolumic contraction and relaxation times. Systolic function frequently is normal, but dysfunction may be elicited by stress tests. Half or more of symptomatic patients have a left ventricular apical aneurysm and other segmental contractile abnormalities similar to those seen in coronary heart disease. The dilated nonsegmental form is indistinguishable from dilated cardiomyopathy. Results from univariate and multivariate Cox survival analyses indicate that impaired systolic function and increased ventricular dimensions have significant value in predicting cardiac morbidity and mortality. Cardiac ultrasound commonly is used in the follow-up of patients and in the assessment of various therapeutic modalities.

Conclusions— Echocardiographic and Doppler techniques provide useful structural and functional information in the detection of early myocardial damage, risk assessment of prognosis, disease progression, and management of patients with Chagas disease.


Key Words: cardiomyopathy • Chagas disease • echocardiography, Doppler • echocardiography • heart failure • survival




This article has been cited by other articles:


Home page
JAMAHome page
C. Bern, S. P. Montgomery, B. L. Herwaldt, A. Rassi Jr, J. A. Marin-Neto, R. O. Dantas, J. H. Maguire, H. Acquatella, C. Morillo, L. V. Kirchhoff, et al.
Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review
JAMA, November 14, 2007; 298(18): 2171 - 2181.
[Abstract] [Full Text] [PDF]